CATHERINE ORJUELA: Open Payments
NPI 1144717133 · SAN JOSE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$137 in 6 payments from 5 companies in 2025. Trend: 2023 $50 · 2024 $25 · 2025 $137
Food & beverage: $137
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| PFIZER INC. | 1 | $32 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
Products named: Kerendia, PREVNAR 20, M-M-R II, BEXSERO, MOUNJARO.
Industry payments across CA — which companies pay providers there.
